BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anlon Healthcare Ltd IPO is open
Apply for the Anlon Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

506128

PARNAXLAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

PARNAX LAB LTD. Share Price Update

As of the latest trading session, PARNAX LAB LTD. share price is currently at ₹ 129.4, which is down by ₹ -3.60 from its previous closing. Today, the stock has fluctuated between ₹ 129.15 and ₹ 137.00. Over the past year, PARNAX LAB LTD. has achieved a return of 14.58 %. In the last month alone, the return has been 0.71 %. Read More...

Investment Returns

Over 1 Month 0.71% Over 3 Months 37.65% Over 6 Months 28.52% Over 1 Year 14.58%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

PARNAX LAB LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    148.90

  • P/E Ratio (TTM)

    266.00

  • Beta

    1.01

  • Book Value / share

    19.62

  • Return on equity

    6.54%

  • EPS (TTM)

    0.50

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.23

info icon alternate text

PARNAX LAB LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 1.97
Operating Expense 1.84
Net Profit 0.23
Net Profit Margin (%) 11.67
Earnings Per Share (EPS) 0.20
EBITDA 0.34
Effective Tax Rate (%) 25.80
Particulars MAR 2025 (Values in Cr)
Revenue 0.84
Operating Expense 1.14
Net Profit -0.08
Net Profit Margin (%) -9.52
Earnings Per Share (EPS) -0.07
EBITDA -0.08
Effective Tax Rate (%) 27.27
Particulars DEC 2024 (Values in Cr)
Revenue 0.99
Operating Expense 0.95
Net Profit 0.16
Net Profit Margin (%) 16.16
Earnings Per Share (EPS) 0.14
EBITDA 0.24
Effective Tax Rate (%) 23.80
Particulars SEP 2024 (Values in Cr)
Revenue 1.54
Operating Expense 1.35
Net Profit 0.27
Net Profit Margin (%) 17.53
Earnings Per Share (EPS) 0.24
EBITDA 0.38
Effective Tax Rate (%) 25.00
Particulars JUN 2024 (Values in Cr)
Revenue 3.66
Operating Expense 2.42
Net Profit 1.05
Net Profit Margin (%) 28.68
Earnings Per Share (EPS) 0.91
EBITDA 1.43
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Revenue 7.02
Operating Expense 5.86
Net Profit 1.39
Net Profit Margin (%) 19.80
Earnings Per Share (EPS) 1.21
EBITDA 1.94
Effective Tax Rate (%) 24.73
Particulars MAR 2024 (Values in Cr)
Revenue 7.44
Operating Expense 5.52
Net Profit 1.82
Net Profit Margin (%) 24.46
Earnings Per Share (EPS) 1.59
EBITDA 2.65
Effective Tax Rate (%) 25.30
Particulars MAR 2023 (Values in Cr)
Revenue 7.47
Operating Expense 6.22
Net Profit 1.20
Net Profit Margin (%) 16.06
Earnings Per Share (EPS) 1.09
EBITDA 1.95
Effective Tax Rate (%) 25.76
Particulars MAR 2022 (Values in Cr)
Revenue 7.15
Operating Expense 6.54
Net Profit 0.54
Net Profit Margin (%) 7.55
Earnings Per Share (EPS) 0.64
EBITDA 1.53
Effective Tax Rate (%) 30.76
Particulars MAR 2021 (Values in Cr)
Revenue 2.37
Operating Expense 3.69
Net Profit -1.13
Net Profit Margin (%) -47.67
Earnings Per Share (EPS) -1.33
EBITDA -0.38
Effective Tax Rate (%) 9.60
Particulars MAR 2024 (Values in Cr)
Book Value / Share 62.32
ROE % 14.39
ROCE % 12.87
Total Debt to Total Equity 1.01
EBITDA Margin 12.91
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.11
ROE % 15.64
ROCE % 14.66
Total Debt to Total Equity 1.12
EBITDA Margin 14.18
Particulars MAR 2022 (Values in Cr)
Book Value / Share 47.24
ROE % 20.47
ROCE % 16.71
Total Debt to Total Equity 1.59
EBITDA Margin 14.33
Particulars MAR 2021 (Values in Cr)
Book Value / Share 38.26
ROE % -1.13
ROCE % 5.67
Total Debt to Total Equity 1.69
EBITDA Margin 11.27
Particulars MAR 2020 (Values in Cr)
Book Value / Share 38.56
ROE % -8.52
ROCE % 3.24
Total Debt to Total Equity 1.36
EBITDA Margin 7.44
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.42
ROE % 6.54
ROCE % 9.09
Total Debt to Total Equity 0.03
EBITDA Margin 35.62
Particulars MAR 2023 (Values in Cr)
Book Value / Share 16.85
ROE % 4.77
ROCE % 6.18
Total Debt to Total Equity 0.32
EBITDA Margin 25.97
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.14
ROE % 3.98
ROCE % 6.24
Total Debt to Total Equity 1.18
EBITDA Margin 21.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.54
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.13
EBITDA Margin -16.03
Particulars MAR 2020 (Values in Cr)
Book Value / Share 6.85
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.63
EBITDA Margin 12.37
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.87
Total Assets 188.76
Total Liabilities 188.76
Total Equity 71.69
Share Outstanding 11485616
Price to Book Ratio 7.03
Return on Assets (%) 5.09
Return on Capital (%) 6.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.78
Total Assets 145.07
Total Liabilities 145.07
Total Equity 62.26
Share Outstanding 11485616
Price to Book Ratio 3.09
Return on Assets (%) 5.94
Return on Capital (%) 7.62
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.78
Total Assets 153.46
Total Liabilities 153.46
Total Equity 48.27
Share Outstanding 9814866
Price to Book Ratio 11.82
Return on Assets (%) 5.37
Return on Capital (%) 7.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.26
Total Assets 106.25
Total Liabilities 106.25
Total Equity 32.62
Share Outstanding 8504866
Price to Book Ratio 3.52
Return on Assets (%) -0.34
Return on Capital (%) -0.41
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.29
Total Assets 107.15
Total Liabilities 107.15
Total Equity 32.86
Share Outstanding 8504866
Price to Book Ratio 1.77
Return on Assets (%) -2.71
Return on Capital (%) -3.64
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.45
Total Assets 22.23
Total Liabilities 22.23
Total Equity 21.15
Share Outstanding 11485616
Price to Book Ratio 7.03
Return on Assets (%) 8.20
Return on Capital (%) 8.62
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.28
Total Assets 21.36
Total Liabilities 21.36
Total Equity 19.35
Share Outstanding 11485616
Price to Book Ratio 3.09
Return on Assets (%) 5.63
Return on Capital (%) 5.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.34
Total Assets 23.53
Total Liabilities 23.53
Total Equity 12.74
Share Outstanding 9814866
Price to Book Ratio 11.82
Return on Assets (%) 2.30
Return on Capital (%) 2.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 17.64
Total Liabilities 17.64
Total Equity 4.71
Share Outstanding 8504866
Price to Book Ratio 3.52
Return on Assets (%) -6.41
Return on Capital (%) -7.02
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 18.65
Total Liabilities 18.65
Total Equity 5.82
Share Outstanding 8504866
Price to Book Ratio 1.77
Return on Assets (%) -10.74
Return on Capital (%) -12.06
Particulars MAR 2024 (Values in Cr)
Net Income 12.04
Cash from Operations 18.51
Cash from Investing -31.51
Cash from Financing 14.81
Net change in Cash -0.82
Free Cash Flow 32.65
Particulars MAR 2023 (Values in Cr)
Net Income 12.27
Cash from Operations 23.77
Cash from Investing -9.92
Cash from Financing -14.06
Net change in Cash -3.08
Free Cash Flow 35.05
Particulars MAR 2022 (Values in Cr)
Net Income 12.26
Cash from Operations 8.78
Cash from Investing -16.49
Cash from Financing 12.13
Net change in Cash 4.18
Free Cash Flow 26.61
Particulars MAR 2021 (Values in Cr)
Net Income -0.08
Cash from Operations 7.06
Cash from Investing -6.56
Cash from Financing 0.05
Net change in Cash -0.20
Free Cash Flow 11.61
Particulars MAR 2020 (Values in Cr)
Net Income -1.96
Cash from Operations 9.81
Cash from Investing -13.33
Cash from Financing 5.02
Net change in Cash 0.43
Free Cash Flow 22.99
Particulars MAR 2024 (Values in Cr)
Net Income 2.44
Cash from Operations 0.09
Cash from Investing 0.30
Cash from Financing -1.21
Net change in Cash -0.82
Free Cash Flow 0.21
Particulars MAR 2023 (Values in Cr)
Net Income 1.62
Cash from Operations -0.26
Cash from Investing 0.13
Cash from Financing -2.92
Net change in Cash -3.06
Free Cash Flow -0.21
Particulars MAR 2022 (Values in Cr)
Net Income 0.77
Cash from Operations -0.35
Cash from Investing 0.00
Cash from Financing 4.59
Net change in Cash 4.23
Free Cash Flow -0.35
Particulars MAR 2021 (Values in Cr)
Net Income -1.25
Cash from Operations 0.47
Cash from Investing 0.00
Cash from Financing -0.47
Net change in Cash 0.00
Free Cash Flow 0.47
Particulars MAR 2020 (Values in Cr)
Net Income -0.47
Cash from Operations 2.18
Cash from Investing -0.01
Cash from Financing -1.54
Net change in Cash 0.63
Free Cash Flow 2.22
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 33.30 13.59 1.82 255.19 30.00 / 69.75
BLISS GVS PHARMA LTD 159.00 15.73 1.59 1677.41 105.05 / 190.65
CIPLA LTD 1601.10 23.98 4.14 129329.50 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 323.75 9.12 2.62 952.83 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 33.30 18.10 5.26 255.19 30.00 / 69.75
AMRUTAJAN HEALTH LTD 708.10 37.55 6.26 2047.16 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8297.10 98.09 26.92 20742.75 6222.35 / 10653.05
BLISS GVS PHARMA LTD 159.00 23.77 1.58 1677.41 105.05 / 190.65

PARNAX LAB LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
129.60 -2.55 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 128.10
  • 26 Days 122.90
  • 10 Days 126.80
  • 50 Days 117.80
  • 12 Days 126.40
  • 100 Days 114.40
  • 20 Days 124.40
  • 200 Days 115.40
125.52 PIVOT

First Support

122.88

First Resistance

129.93

Second Support

118.47

Second Resistance

132.57

Third Support

115.83

Third Resistance

136.98

RSI

58.43

ADX

38.02

MACD

3.04

Williams % R

-45.45

Commodity Channel Index (CCI)

39.49

Date

2025-08-25

Week

4213.00

Same Day

4097.00

Month

4786.00

1 Year

1.05

3 Year

0.71

Over 1 Month

0.71%

down

Over 1 Year

14.58%

down

Over 3 Months

37.65%

down

Over 3 Years

11.90%

down

Over 6 Months

28.52%

down

Over 5 Years

44.79%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

PARNAX LAB LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

PARNAX LAB LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

PARNAX LAB LTD. Share Price

Parnax Lab Limited (Formerly Known as Krishna Deep Trade & Investment Ltd ) was incorporated in August, 1982. The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited effective on July 19, 2012. The Company is principally engaged in the business activities of manufacturing and export of Pharmaceutical Formulations. Initially, it was engaged in investment and financing activities.

Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company. With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations & Nutraceuticals (FSSAI) products. The Naxpar Group is headquartered in Mumbai, India. It is as a result of their diligence and perseverance that Naxpar's prowess in pharmaceutical manufacturing has seen exponential growth and achievement, significant milestones such as the coveted ISO 9002 status from RWTUV, Germany for following Good Quality Systems in manufacturing and marketing of formulations for domestic and international markets. Naxpar initially began as a single-establishment - indicative of its resounding success and growing client base, the Company now has state-of-the-art accredited manufacturing facilities with high speed packing lines in
Silvassa, in Dadra & Nagar Haveli and Baddi in Himachal Pradesh.

Naxpar's key strength is manufacturing finished formulations for multinationals in India and abroad and in emerging pharmaceutical markets such as Nigeria, Kazakhstan, Kenya, Mauritius etc. The WHO-approved and EHS-compliant Company is now well placed to venture into markets such as South East Asia, CIS, LatAm etc. where it is keen to establish its presence as a leading pharmaceuticals, cosmetics and herbal products manufacturer.

Parent organization Indian Private
NSE symbol [-]
Founded 1982
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Parnax Lab Ltd?

Answer Field

Parnax Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 129.60 as on Aug 28 2025 03:29 PM.

What is the Market Cap of Parnax Lab Ltd Share?

Answer Field

The market cap of Parnax Lab Ltd for NSE ₹ 0.00 & for BSE ₹ 148.90 as on Aug 28 2025 03:29 PM.

What is the 52 Week High and Low of Parnax Lab Ltd?

Answer Field

The 52 Week High and Low of Parnax Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 193.50 and ₹ 81.00.

What is 1 year return for Parnax Lab Ltd?

Answer Field

The 1 year returns on the stock has been 19.71%.

What is the P/E Ratio of Parnax Lab Ltd Share?

Answer Field

As on Aug 28 2025 03:29 PM the price-to-earnings (PE) ratio for Parnax Lab Ltd share is 266.00.

What is the PB ratio of Parnax Lab Ltd Share?

Answer Field

As on Aug 28 2025 03:29 PM, the price-to-book (PB) ratio for Parnax Lab Ltd share is 19.62.

How to Buy Parnax Lab Ltd Share?

Answer Field

You can trade in Parnax Lab Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Parnax Lab Ltd Share on Bajaj Broking App?

Answer Field

To buy Parnax Lab Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Parnax Lab Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91